Landmark Review: The PALMFlexS trial

In this review: 

This publication will present and discuss the findings of the PALMFlexS study of the long-acting injectable  antipsychotic paliperidone palmitate in patients with clinically stable but symptomatic (nonacute) schizophrenia who were switched from oral antipsychotic agents.

Download PDF Subscribe